Mr. Peterson has over 25 years’ experience developing medical device and combination products, leading to commercial launch of over a dozen products globally. He has held leadership positions at both S&P500 companies and start-ups. Mr. Peterson has a successful history leading R&D programs in US, EU and AsiaPac from ideation through Phase I-III clinical trials and to regulatory approval. He is a veteran of multiple pharma startup companies with successful exits including Evolus (IPO), TargeGen (sale to Sanofi-Aventis) and Somaxon (IPO).